|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 271.50 SEK | +0.37% |
|
+3.23% | +2.26% |
| Jan. 16 | Diary - Europe's Stoxx 600 Corporate Earnings Week Ahead | RE |
| Jan. 15 | Espiria Hållbar Framtid Rises 0.4 Percent in December — Increased Holdings in Epiroc and Afry | FW |
Business description: Essity AB
- human care products (54.2%): incontinence products (Tena), feminine protection products (Libresse, Bodyform, Nana, Nuvenia, Saba, Nosotras, Donnasept, etc.), diapers (Libero, Up & Go, Libero-Peaudouce, Drypers, Pequenin, etc.), compresses and bandages.
- paper hygiene products (26.1%): paper towels, toilet paper, handkerchiefs, wipes, etc. sold under Tempo, Colhogar, Cozy, Cushelle, Danke, Delica, Demak Up, Favorita, Flen, Lotus, Lovly, Okay, Plenty, Regio and Zewa brands;
- professional hygiene products (19.7%): including toilet paper, handkerchiefs, hand lotions and hand soaps, hand sanitizers, as well as cleaning and wiping products.
At the end of 2024, the group operated around 70 production sites in the world.
Net sales are distributed geographically as follows: Europe (60.2%), Latin America (17.5%), North America (16.9%), Asia (1.7%), and others (3.7%).
Number of employees: 36,000
Sales by Activity: Essity AB
| Fiscal Period: December | 2020 (SEK) | 2021 (SEK) | 2022 (SEK) | 2023 (SEK) | 2024 (SEK) |
|---|---|---|---|---|---|
Consumer Goods | 50.22B | 49.09B | 94.84B | 79.91B | 78.89B |
Professional Hygiene | 25.42B | 26.14B | 36.11B | 39.48B | 38.07B |
Health & Medical | 46.1B | 46.64B | 25.24B | 27.73B | 28.6B |
Other | 18M | -1M | -21M | 25M | -12M |
Geographical breakdown of sales: Essity AB
| Fiscal Period: December | 2020 (SEK) | 2021 (SEK) | 2022 (SEK) | 2023 (SEK) | 2024 (SEK) |
|---|---|---|---|---|---|
USA | 12.88B | 13.1B | 18.18B | 21.84B | 20.86B |
Germany | 14.27B | 12.55B | 16.75B | 19.3B | 19.25B |
Mexico | 6.25B | 6.75B | 9.26B | 12.06B | 12.54B |
France | 10.27B | 9.69B | 11.9B | 12.55B | 12.33B |
UK | 9.13B | 9.15B | 11.23B | 11.64B | 11.56B |
Spain | 5.59B | 5.38B | 6.98B | 8.18B | 8.08B |
Netherlands | 4.13B | 3.88B | 4.5B | 5.3B | 5.4B |
Colombia | 3.75B | 3.96B | 4.79B | 4.9B | 5.24B |
Italy | 3.62B | 3.59B | 4.38B | 4.8B | 4.86B |
Sweden | 3.48B | 3.57B | 3.99B | 4.25B | 4.13B |
Canada | 1.99B | 2B | 2.97B | 3.75B | 3.68B |
Austria | 2.17B | 2.09B | 2.77B | 3.33B | 3.34B |
Australia | - | 1.45B | 2.9B | 3.06B | 3.18B |
Belgium | 1.8B | 1.63B | 1.94B | 2.21B | 2.2B |
Finland | 1.65B | 1.6B | 1.83B | 2.15B | 2.16B |
Switzerland | 1.54B | 1.43B | 1.98B | 2.05B | 2.1B |
Poland | 1.04B | 1.07B | 1.36B | 1.74B | 2.02B |
Norway | 1.3B | 1.43B | 1.78B | 1.86B | 1.93B |
Denmark | 1.45B | 1.45B | 1.77B | 1.92B | 1.93B |
Hungary | 1.15B | 1.14B | 1.42B | 1.66B | 1.68B |
Ecuador | 1.49B | 1.39B | 1.74B | 1.77B | 1.56B |
Brazil | 526M | 635M | 1.02B | 1.4B | 1.46B |
New Zealand | - | 674M | 1.26B | 1.37B | 1.29B |
Chile | 883M | 1.02B | 1.2B | 1.43B | 1.23B |
Czech Republic | 687M | 750M | 922M | 1.12B | 1.09B |
Costa Rica | 588M | 549M | 719M | 980M | 945M |
Argentina | 369M | 358M | 648M | 856M | 843M |
Slovakia | 474M | 483M | 619M | 784M | 830M |
Peru | 550M | 483M | 665M | 722M | 743M |
Ireland | 507M | 522M | 662M | 692M | 679M |
Romania | 393M | 408M | 495M | 606M | 629M |
South Africa | 352M | 382M | 435M | 469M | 542M |
Ukraine | 352M | 355M | 420M | 534M | 519M |
Dominican Republic | 442M | 452M | 625M | 556M | 513M |
Rest of Asia | 663M | 665M | 765M | 358M | 497M |
Lithuania | 236M | 252M | 322M | 424M | 447M |
Portugal | 335M | 339M | 396M | 432M | 434M |
Japan | 646M | 580M | 533M | 538M | 427M |
Greece | 306M | 270M | 337M | 361M | 340M |
Indonesia | - | - | 257M | 277M | 295M |
India | 155M | 187M | 233M | 274M | 287M |
Latvia | - | - | 230M | 245M | 279M |
Rest of Latin America | 367M | 345M | 216M | 231M | 268M |
Turkey | 280M | 222M | 249M | 241M | 256M |
Estonia | - | - | 204M | 235M | 242M |
Other | 655M | 105M | 194M | 210M | 218M |
Puerto Rico | - | - | 194M | 234M | 214M |
South Korea | - | - | 243M | - | - |
Singapore | 263M | 253M | 315M | - | - |
Tunisia | 451M | - | - | - | - |
Morocco | 70M | - | - | - | - |
Taiwan | 398M | 380M | - | - | - |
Malaysia | 2.06B | 2.04B | 2.39B | - | - |
China | 16.42B | 17.49B | 21.44B | - | - |
Russia | 3.06B | 3.04B | 3.56B | 1.24B | - |
Rest of EU Excluding Sweden | 336M | 319M | - | - | - |
Executive Committee: Essity AB
| Manager | Title | Age | Since |
|---|---|---|---|
Ulrika Kolsrud
CEO | Chief Executive Officer | 55 | 2025-05-31 |
Carl Rystedt
DFI | Director of Finance/CFO | 63 | 2016-12-31 |
| Chief Tech/Sci/R&D Officer | 60 | 2023-05-14 | |
Sandra Åberg
IRC | Investor Relations Contact | - | 2023-08-31 |
Juanita Mesa
LAW | General Counsel | - | - |
Composition of the Board of Directors: Essity AB
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 2015-12-31 | |
| Director/Board Member | 69 | 2015-12-31 | |
| Director/Board Member | 67 | 2015-12-31 | |
Örjan Svensson
BRD | Director/Board Member | 63 | 2016-12-31 |
Susanna Lind
BRD | Director/Board Member | 60 | 2018-12-31 |
Torbjörn Lööf
BRD | Director/Board Member | 61 | 2021-02-28 |
Maria Carell
BRD | Director/Board Member | 53 | 2022-12-31 |
Jan Gurander
CHM | Chairman | 65 | 2024-03-20 |
| Director/Board Member | 47 | - | |
| Director/Board Member | 45 | 2025-03-26 |
Holdings: Essity AB
| Name | Equities | % | Valuation |
|---|---|---|---|
ESSITY AB 1.38% | 8,783,385 | 1.38% | 253 M $ |
Company details: Essity AB

Group companies: Essity AB
| Name | Category and Sector |
|---|---|
Essity Operations Goa Ltd. | |
Essity Germany GmbH
Essity Germany GmbH Manufactures, markets and distributes personal care, consumer tissue and professional hygiene products | |
Essity Germany GmbH
Essity Germany GmbH Manufactures, markets and distributes personal care, consumer tissue and professional hygiene products | |
BSN Medical, Inc.
BSN Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies medical equipment |
Medical Specialties
|
BSN Medical, Inc.
BSN Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies medical equipment |
Medical Specialties
|
Other Personal Products
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.07% | +1.87% | -10.30% | -3.93% | 338B | ||
| -0.40% | +0.37% | -7.73% | +1.61% | 141B | ||
| +0.21% | +3.73% | -4.70% | +8.04% | 68.13B | ||
| +0.29% | -0.51% | +0.27% | -11.51% | 67.24B | ||
| -0.52% | +1.16% | +47.77% | -56.92% | 41.46B | ||
| -0.35% | +2.20% | -18.48% | - | 32.95B | ||
| +0.26% | +3.56% | -22.04% | -11.29% | 24.94B | ||
| +0.82% | +0.59% | +4.14% | +33.10% | 13.95B | ||
| +0.16% | -1.50% | -2.19% | -7.55% | 10.06B | ||
| Average | +0.04% | +1.27% | -1.47% | -6.06% | 81.95B | |
| Weighted average by Cap. | -0.08% | +1.50% | -5.44% | -5.08% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ESSITY B Stock
- ESSITY A Stock
- Company Essity AB
Select your edition
All financial news and data tailored to specific country editions

















